Effects of formula supplementation in breast-fed infants with failure to thrive

Irena Hren1, Natasa Fidler Mis, Jernej Brecelj

  • 1Dietetics and Nutrition Unit, University Medical Centre, Ljubljana, Slovenia.

Insights

Formula supplementation improved growth in infants with failure to thrive, maintaining breastfeeding in most cases. This intervention offers a viable option for enhancing infant weight gain without compromising the breastfeeding relationship.

Area of Science:

  • Pediatrics
  • Infant Nutrition
  • Growth Monitoring

Background:

  • Infants with failure to thrive often present with underweight and require nutritional support.
  • Assessing the impact of formula supplementation on growth while preserving breastfeeding is crucial.

Purpose of the Study:

  • To evaluate if formula supplementation can improve underweight in infants experiencing failure to thrive.
  • To determine if breastfeeding can be maintained during formula supplementation.

Main Methods:

  • A prospective intervention study involved 31 exclusively breast-fed infants diagnosed with failure to thrive.
  • Infants received ad libitum infant formula after each breastfeeding session, with continued breastfeeding support.

Main Results:

  • Daily energy intake significantly increased with formula supplementation.
  • While human milk intake decreased, 81% of infants continued partial or full breastfeeding.
  • Supplementation over 31 days resulted in significant improvements in weight, length, and head circumference standard deviation scores.

Conclusions:

  • Formula supplementation is an effective method to improve growth in infants with failure to thrive.
  • This approach successfully enhanced growth in 72% of participants while preserving breastfeeding in the majority.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...